SID 2026Abstract 0379Observational study
Comparative effectiveness and safety of upadacitinib versus abrocitinib for moderate-to-severe atopic dermatitis
A retrospective real world study
Hu Y, Zhang J, Zhao Y
SID Annual Meeting 2026Chicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: Atopic dermatitis & eczema
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.410 · Not in PubMed: details from Crossref